K.A. Althage
University of Arkansas for Medical Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by K.A. Althage.
Journal of Investigative Medicine | 2005
J. M. Campbell; Tamara T. Perry; Lynn Christie; K.A. Althage; S.K. Carlisle; A.W. Burks; J. G. Parker; Stacie M. Jones
Purpose To compare food-specific IgE levels and age of passed or failed oral food challenges (FC) and examine the severity of failed FC. Methods We performed a retrospective review of food allergic patients who underwent milk, egg, soy, wheat, and peanut FC (January 2000-June 2004) based on known predictive IgE levels. Food-specific IgE and age were determined for those who passed or failed challenges. System involvement and treatment of failed challenges were analyzed. Results One hundred sixty-three FC were performed in 106 patients (67% male; 83% Caucasian; 66% atopic comorbidities). 56% of FC were blinded, 43% open. Negative challenges occurred in 97/163 (60%) - milk 47%, egg 61%, peanut 66%, soy 61%, and wheat 63%. Median age (years) of those passing challenges was: milk 3.2; egg 4.5; peanut 5.1; soy 2.3; wheat 3.6. For failed challenges median age was milk 2.0; egg 4.4; peanut 4.0; soy 4.6; and wheat 4.0. Median food-specific IgE levels (kUA/L) for passed FC were milk 1.6; egg 0.7; peanut 0.7; soy 0.7; and wheat 6.7. IgE levels for failed challenges were milk 4.5; egg 0.7; peanut 1.4; soy 20; and wheat 7.5. For failed challenges, 80% had cutaneous involvement, 32% upper respiratory, 23% lower respiratory, and 32% gastrointestinal. Positive challenges were successfully treated with antihistamines (80%), bronchodilators (8%), charcoal (2%), epinephrine (11%), and fluids/corticosteroids (2%), while 8% required no treatment. Conclusions For patients with low food-specific IgE levels approaching 95th% negative predictive value, FC can be performed safely, with minimal symptoms and with the majority of patients showing clinical tolerance.
The Journal of Allergy and Clinical Immunology | 2007
A.D. Buchanan; Todd D. Green; Stacie M. Jones; Amy M. Scurlock; Lynn Christie; K.A. Althage; Pamela H. Steele; L. Pons; Rick M. Helm; Laurie A. Lee; A. Wesley Burks
The Journal of Allergy and Clinical Immunology | 2002
Amy M. Scurlock; K.A. Althage; Lynn Christie; Rd; A. Wesley Burks; Stacie M. Jones
The Journal of Allergy and Clinical Immunology | 2007
S.D. Nash; Pamela H. Steele; J. Kamilaris; L. Pons; M. Kulis; Laurie A. Lee; K.A. Althage; Lynn Christie; Amy M. Scurlock; Stacie M. Jones; A.W. Burks
Regulatory Toxicology and Pharmacology | 2001
A. Wesley Burks; Lynn Christie; K.A. Althage; Julie M. Kesler; Gregory S. Allgood
The Journal of Allergy and Clinical Immunology | 2005
Amy M. Scurlock; Pamela H. Steele; S. Andrzejewski; L. Pons; K.A. Althage; Lynn Christie; S.K. Carlisle; A.D. Buchanan; Stacie M. Jones; A.W. Burks
The Journal of Allergy and Clinical Immunology | 2009
Lynn Christie; K.A. Althage; Amy M. Scurlock; Tamara T. Perry; L. Pons; Pamela H. Steele; J. Kamilaris; Stacie M. Jones; A.W. Burks
The Journal of Allergy and Clinical Immunology | 2008
Alison Hofmann; Pamela H. Steele; J. Kamilaris; Stacie M. Jones; K.P. Palmer; Tamara T. Perry; Amy M. Scurlock; K.A. Althage; A.W. Burks
The Journal of Allergy and Clinical Immunology | 2005
Lynn Christie; K.A. Althage; A.W. Burks; Amy M. Scurlock; Tamara T. Perry; A.D. Buchanan; Ricki M. Helm; L. Pons; S. Andrzejewski; Pamela H. Steele; Stacie M. Jones
The Journal of Allergy and Clinical Immunology | 2005
J.M. Campbell; Tamara T. Perry; Lynn Christie; K.A. Althage; S.K. Carlisle; A.W. Burks; J.G. Parker; Stacie M. Jones